Font Size: a A A

Three-Dimensional Conformal Radiotherapy Combined With Transarterial Chemoembolization In Primary Liver Cancer With Portal Vein Thrombosis

Posted on:2016-06-28Degree:MasterType:Thesis
Country:ChinaCandidate:H R LuFull Text:PDF
GTID:2284330461465282Subject:Oncology
Abstract/Summary:PDF Full Text Request
Purpose:To evaluate the efficacy of three-dimensional conformal radiotherapy(3DCRT) combined with transarterial chemoembolization (TACE),3DCRT alone and TACE alone in advanced primary liver cancer(PLC) with portal vein tumor thrombosis(PVTT) and investigate the prognostic factors.Methods:Between January 2000 and June 2013,182 patients diagnosed by PLC with PVTT were retrospectively analyzed. According to Barcelona staging of liver cancer (BCLC), all patients were BCLC stage C,including 68 patients treated with 3DCRT alone;74 patients treated with TACE alone and 40 patients treated with 3DCRT combined with TACE. Kaplan-Meier method was used to calculate the cumulative survival rates and single-factor analysis. Using a Cox regression (proportional hazards model) method for multiple factors that may affect the prognosis. Tumor response, overall survival rate and toxicity were analyzed.Results:The total effective rate (CR+PR) of all patients was 39.6% (72/182). The median survial time was 8.5 mouths.The survial rates at 1,2,3 and 5 years were 35.4%,14.2%,6.4% and 2.6% respectively. Child-pugh grade, serum AFP level and treatment of 3DCRT combined with TACE are independent prognostic factors influencing survival by Cox regression analysis.There was no significant statistical differences (P> 0.05) between the three treatments in the objective response rate. The patients treated with 3DCRT combined with TACE had a median survial time of 13.2 mouths,which was higher than the patients treated with 3DCRT alone and TACE alone (P<0.05).Conclusions:Child-pugh grade, serum AFP level and treatment of 3DCRT combined with TACE have significant impact on the overall survival in PLC patients with PVTT. There was no significant difference in response rate between the three treatments for PLC with PVTT,but the treatment of 3DCRT combined with TACE can significantly improve long-term survival compared with 3DCRT alone or TACE alone.
Keywords/Search Tags:Liver cancer, Portal vein tumor thrombus, Three-dimensional conformal radiotherapy, Transarterial chemoembolization, Prognosis
PDF Full Text Request
Related items
Transarterial Chemoembolization For Primary Liver Cancer With Portal Vein Tumor Thrombus
Efficacy Of The Treatment Of Transarterial Chemoembolization Combined With Radiotherapy For Hepatocellular Carcinoma With Portal Vein Tumor Thrombus
The Survival Analysis Of Transarterial Chemoembolization Plus Three Dimensional Radiotherapy For Hepatocellular Carcinoma Combined With Portal Vein Tumor Thrombosis
Hepatocellular Carcinoma With Portal Vein Tumor Thrombus Treated With Transarterial Chemoembolization Combined With Sorafenib Versus Transarterial Chemoembolization Combined With 125 Iodine Implantation:A Prospective,Multicenter,Controlled Study
Inical Research Of Tace With3-dcrt To Treat Primary Hepatic Carcinoma With Portal Vein Tumor Thrombus
Survival Prognosis Of Patients With Hepatocellular Carcinoma And Portal Vein Tumor Thrombus After Adjuvant Hepatic Transcatheter Arterial Chemoembolization Combined With Portal Vein Chemotherapy
Hepatic Arterial Chemoembolization In Combination With Sorafenib For Primary Liver Cancer With Portal Vein Tumor Thrombus
Transcatheter Hepatic Arterial Chemoem Bolization Followed By Three-dimentional Conformal Radiotherapy For The Treatment Of Primary Hepatic Cancer With Portal Vein Tumor Thrombus
Three-dimensional Conformal Radiotherapy Combined With TACE VersusSurgical Resection For Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Comparative Study
10 The Study Of Metallic Stent Implantation Combined By External Radiation Therapy In HCC Patients With Portal Vein Tumor Thrombus